Skip to main content
. 2015 Dec 15;7(4):4806–4816. doi: 10.18632/oncotarget.6624

Table 1. Specifications of primary antibodies used in the TMA.

Marker Clone Brand Dilution pH antigen retrieval Time of antigen retrieval Positive Control
CD10 56C6 mouse Dako 1:2 Tris-EDTA pH 9.0 20 min 97°C Palatine tonsil
BCL6 LN22 mouse Novocastra 1:100 Citrate
pH 6.1
20 min 97°C Palatine tonsil
MUM1 MUM1p mouse Novocastra 1:1200 Citrate
pH 6.1
20 min 97°C Palatine tonsil
CD68 KP1 mouse Dako 1:6000 Citrate
pH 6.1
20 min 97°C Palatine tonsil
SPARC H-90 Santa Cruz Biotechnology 1:500 Citrate
pH 6.1
20 min 97°C Kidney
CD34 QBEnd10 mouse Dako 1:800 Citrate
pH 6.1
20 min 97°C Prostate